Bioten Co., Ltd. (XKON:289170)

Bioten Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec 31, 2022	Dec 31, 2021
Operating Revenue	10,706	6,069
Other Revenue	-	-0
Revenue	10,706	6,069
Revenue Growth (YoY)	76.39%	-
Cost of Revenue	6,782	4,246
Gross Profit	3,924	1,824
Selling, General & Admin	1,731	1,070
Research & Development	319.2	239.52
Other Operating Expenses	26.19	20.37
Operating Expenses	2,147	1,414
Operating Income	1,777	409.13
Interest Expense	-109.51	-105.47
Interest & Investment Income	1.82	0.17
Currency Exchange Gain (Loss)	5.05	1.36
Other Non Operating Income (Expenses)	-423.25	-138.03
EBT Excluding Unusual Items	1,251	167.16
Gain (Loss) on Sale of Assets	1.81	-
Asset Writedown	-229.28	-
Pretax Income	1,023	167.16
Net Income	1,023	167.16
Net Income to Common	1,023	167.16
Net Income Growth	512.27%	-
Shares Outstanding (Basic)	3	3
Shares Outstanding (Diluted)	3	3
Shares Change (YoY)	9.80%	-
EPS (Basic)	329.00	59.00
EPS (Diluted)	329.00	59.00
EPS Growth	457.63%	-
Free Cash Flow	2,080	1,034
Free Cash Flow Per Share	668.55	364.94
Gross Margin	36.65%	30.04%
Operating Margin	16.60%	6.74%
Profit Margin	9.56%	2.75%
Free Cash Flow Margin	19.43%	17.04%
EBITDA	1,885	521.12
EBITDA Margin	17.60%	8.59%
D&A For EBITDA	107.88	111.99
EBIT	1,777	409.13
EBIT Margin	16.60%	6.74%
Advertising Expenses	11.4	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.